As of 2026-09-25, the Relative Valuation of Royalty Pharma PLC (RPRX) is 50.33 USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.29 USD, the upside of Royalty Pharma PLC based on Relative Valuation is -13.7%.
The range of the Relative Valuation is 43.88 - 53.09 USD.
| Range | Selected | |
| Trailing P/E multiples | 31.0x - 37.4x | 34.2x |
| Forward P/E multiples | 21.7x - 22.4x | 22.0x |
| Fair Price | 43.88 - 53.09 | 50.33 |
| Upside | -24.7% - -8.9% | -13.7% |
| Date | P/E |
| 2026-09-24 | 41.18 |
| 2026-09-23 | 40.73 |
| 2026-09-22 | 41.35 |
| 2026-09-21 | 41.29 |
| 2026-09-18 | 41.27 |
| 2026-09-17 | 41.64 |
| 2026-09-16 | 41.31 |
| 2026-09-15 | 41.31 |
| 2026-09-14 | 41.72 |
| 2026-09-11 | 41.41 |
| 2026-09-10 | 41.51 |
| 2026-09-09 | 42.81 |
| 2026-09-08 | 42.81 |
| 2026-09-04 | 45.19 |
| 2026-09-03 | 45.13 |
| 2026-09-02 | 44.59 |
| 2026-09-01 | 44.03 |
| 2026-08-31 | 43.39 |
| 2026-08-28 | 42.99 |
| 2026-08-27 | 43.75 |
| 2026-08-26 | 43.66 |
| 2026-08-25 | 43.86 |
| 2026-08-24 | 43.33 |
| 2026-08-21 | 43.32 |
| 2026-08-20 | 42.80 |
| 2026-08-19 | 43.61 |
| 2026-08-18 | 42.17 |
| 2026-08-17 | 42.00 |
| 2026-08-14 | 41.40 |
| 2026-08-13 | 41.38 |
| 2026-08-12 | 41.84 |
| 2026-08-11 | 40.83 |
| 2026-08-10 | 40.96 |
| 2026-08-07 | 40.11 |
| 2026-08-06 | 40.46 |
| 2026-08-05 | 40.80 |
| 2026-08-04 | 40.61 |
| 2026-08-03 | 40.39 |
| 2026-07-31 | 41.28 |
| 2026-07-30 | 41.70 |
| 2026-07-29 | 41.81 |
| 2026-07-28 | 42.37 |
| 2026-07-27 | 41.50 |
| 2026-07-24 | 41.57 |
| 2026-07-23 | 41.70 |
| 2026-07-22 | 41.49 |
| 2026-07-21 | 41.28 |
| 2026-07-20 | 40.48 |
| 2026-07-17 | 41.11 |
| 2026-07-16 | 41.35 |